Topic

Mike Hollan is an assistant managing editor for 

 and can be reached at mhollan@mjhlifesciences.com.

Articles

McCullar discusses his new role as CEO of RegCell.

Fighting Autoimmune Diseases and Developing Leadership Skills Along the Way: Q&A With Dr. Mike McCullar, CEO of RegCell

Michael Wong is an emeritus board member of the Harvard Business School Healthcare Alumni Association (HBSHAA).

C-Suites and their boards should remember that digital transformation is a key part of the larger focus of a profound business transformation.

As Biopharma Firms Finalize C-Suite Goals for 2024, Are Their Workforces Prepared to Execute? A Q&A With MIT’s Stephanie L. Woerner, PhD

The Alliance for mRNA Medicines is the first and only scientific and policy organization singularly focused on advancing and advocating for global mRNA innovation.

Alliance for mRNA Medicines Launched to Advance the Promise of This Revolutionary Technology

Meg Rivers is the former managing editor of 

Julie Louise Gerberding, president and CEO of the Foundation for the National Institutes of Health (FNIH) and former lead of the CDC, shares insight into her experience at the CDC and FNIH in this Q&A with Pharm Exec.

An Inside Look into the CDC and FNIH

In this latest Harvard Business School Healthcare Alumni Association Q&A, JT Saunders, Chief Diversity Officer at global consulting firm Korn Ferry, discusses diversity in pharma, as well as what mentors and mentees should be considering in the workplace. 

Diversity and Mentoring at BioPharmas: A C-Suite Q&A with Korn Ferry’s JT Saunders

Senior Partner, Leadership Advisory, WittKieffer

Senior Partner, Life Sciences, WittKieffer

Global Leader, Commercial Strategy and Insights, WittKieffer

The core building blocks of trust must be operationalized for pharma companies to strengthen their social contract, deliver business value, and improve patients’ quality of life.

Measuring Pharma’s Trust Performance

The impact on clinical trial staffing would be particularly significant.

How Pharma Should Prepare for Looming Nursing Shortage

Pharm Exec profiles its 2023 Emerging Pharma Leaders.

Pharmaceutical Executive's 2023 Emerging Pharma Leaders

Videos

The 2023 Emerging Pharma Leaders share with the Pharmaceutical Executive editors what makes a good leader, what has made them the proudest in their career, lessons they wish they had known when starting out, and more. (This is the video podcast of the Pharm Exec Podcast episode!)

Pharm Exec VIDEO Podcast: Emerging Potential: Changing Lives One Story, One Therapeutic at a Time 

Winselow Tucker, chief commercial officer, Loxo@Lilly (Eli Lilly’s oncology unit), discusses where to make budget cuts, how to motivate a team, what he wishes he had known earlier in his career, as well as his new role at Loxo@Lilly.